Literature DB >> 8621137

The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy.

K D Lindor1, C Bru, R A Jorgensen, J Rakela, J M Bordas, J B Gross, J Rodes, D B McGill, C C Reading, E M James, J W Charboneau, J Ludwig, K P Batts, A R Zinsmeister.   

Abstract

The risk of complications from percutaneous liver biopsy is low, but discomfort is common and complications require hospitalization in approximately 4% of patients. The optimal method of performing these biopsies is unknown. The goal of our study was to determine whether the use of ultrasonography in the biopsy room immediately prior to or during the procedure would lessen the risk of complications and to compare the safety and efficacy in obtaining tissue by use of a Trucut needle versus an automatic biopsy needle. Between 1992 and 1994, 836 patients were entered into a randomized study (489 in Rochester, MN; 347 in Barcelona, Spain). Patients were randomized immediately prior to liver biopsy into four groups: Trucut needle, or automatic biopsy needle, and with or without ultrasonography. Fisher's Exact Test and a logistic regression model were also used to assess the effect of needle and ultrasonography on the odds for complications. The four biopsy groups were well-matched at entry with respect to age, sex, underlying liver disease, hemoglobin, prothrombin time, and platelet count. The use of ultrasound was associated with a decreased rate of hospitalization for pain, hypotension, or bleeding (2 vs. 9, P < .05). No difference in safety was found between the two types of needles. The number of passes needed to obtain specimens was similar for all four groups. The average length of the specimen was slightly greater with ultrasonographic-guided biopsies (1.7 mm vs. 1.6 mm, P < .05) and with biopsies obtained using the automatic biopsy needle when compared with the Trucut needle (1.7 mm vs. 1.5 mm, P < .05), but this did not seem to be clinically important. The addition of ultrasonography reduces complications in patients undergoing percutaneous liver biopsy. The type of needle appears to offer little difference in safety or yield of diagnostic tissue. The use of ultrasonography for guidance of percutaneous liver biopsy will lead to a lower rate of complications. The value of this benefit must be weighed against the added cost of ultrasonographic guidance.

Entities:  

Mesh:

Year:  1996        PMID: 8621137     DOI: 10.1002/hep.510230522

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  47 in total

1.  Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey.

Authors:  W Mayoral; J H Lewis
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Liver biopsy: when, how, by whom, and where?

Authors:  D B McGill
Journal:  Curr Gastroenterol Rep       Date:  2001-02

3.  Predictors of pain medication use after percutaneous liver biopsy.

Authors:  Thomas R Riley
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

4.  Simple tests to predict hepatic fibrosis in nonalcoholic chronic liver diseases.

Authors:  Woon Geon Shin; Sang Hoon Park; Sun-Young Jun; Jae One Jung; Joon Ho Moon; Jong Pyo Kim; Kyoung Oh Kim; Cheol Hee Park; Tai Ho Hahn; Kyo-Sang Yoo; Jong Hyeok Kim; Choong Kee Park
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

5.  The effect of processing on liver biopsy core size.

Authors:  Thomas R Riley; Francesca M Ruggiero
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

6.  Percutaneous liver biopsy practice patterns among Canadian hepatologists.

Authors:  Mohammed Aljawad; Eric M Yoshida; Julia Uhanova; Paul Marotta; Natasha Chandok
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

Review 7.  Role of interventional radiology in managing pediatric liver tumors : Part 2: percutaneous interventions.

Authors:  C Matthew Hawkins; Alexander J Towbin; Derek J Roebuck; Eric J Monroe; Anne E Gill; Avnesh S Thakor; Richard B Towbin; Anne Marie Cahill; Matthew P Lungren
Journal:  Pediatr Radiol       Date:  2018-02-02

8.  Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy.

Authors:  Daniela Petz; Sabine Klauck; Friedrich-Wilhelm Röhl; Peter Malfertheiner; Albert Roessner; Christoph Röcken
Journal:  Virchows Arch       Date:  2003-01-28       Impact factor: 4.064

9.  Routine ultrasound-guided liver biopsy versus echo-assisted procedure in viral chronic hepatitis.

Authors:  R Chiavaroli; P F Grima; P Calabrese; P Grima
Journal:  Radiol Med       Date:  2008-09-25       Impact factor: 3.469

Review 10.  Is liver biopsy still needed in children with chronic viral hepatitis?

Authors:  Maria Pokorska-Śpiewak; Barbara Kowalik-Mikołajewska; Małgorzata Aniszewska; Magdalena Pluta; Magdalena Marczyńska
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.